Denmark
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Logo
  • Produkter
  • Om os
  • Nyheder
  • Kontakt os
  • Bæredygtighed
  • Aidian Academy
  • Antimicrobial resistance
Søg
Logo
  • Point of care
  • Mikrobiologi
  • Hæmatologi
  • Molekylær mikrobiologi
  • Molekylær onkologi
  • Hygiejneovervågning
  • RIA / Collagener
  • COVID-19
  • Andre
Point of care
  • QuikRead go
  • QuikRead 101
  • Aidian LF
  • microINR
  • Certest
  • FACIT
  • SD BIOSENSOR STANDARD™ F
  • bioLytical Laboratories INSTI®
  • Nova Biomedical
  • Pulsar
  • GenSure
  • ACRO™ Biotech
Læs mere
QuikRead go
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult / Uricult Trio-tests
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
Læs mere
Hæmatologi
  • Norma Icon
  • Pixcell Medical – HemoScreen™
Læs mere
Molekylær mikrobiologi
  • ELITech Molecular Diagnostics
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD™ M10
Læs mere
Molekylær onkologi
  • Nucleix – Bladder EpiCheck®
Læs mere
Hygiejneovervågning
  • Easicult
  • Hygicult
  • Clean Card PRO
Læs mere
RIA / Collagener
  • UniQ RIA
Læs mere
COVID-19
  • COVID-19-tests
Læs mere
Andre
  • Grifols Promonitor®
Læs mere
Logo
Tæt
  • Produkter
    • Point of care
      • QuikRead go
      • QuikRead 101
      • Aidian LF
      • microINR
      • Certest
      • FACIT
      • SD BIOSENSOR STANDARD™ F
      • bioLytical Laboratories INSTI®
      • Nova Biomedical
      • Pulsar
      • GenSure
      • ACRO™ Biotech
    • Mikrobiologi
      • Uricult / Uricult Trio-tests
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
    • Hæmatologi
      • Norma Icon
      • Pixcell Medical – HemoScreen™
    • Molekylær mikrobiologi
      • ELITech Molecular Diagnostics
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD™ M10
    • Molekylær onkologi
      • Nucleix – Bladder EpiCheck®
    • Hygiejneovervågning
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagener
      • UniQ RIA
    • COVID-19
      • COVID-19-tests
    • Andre
      • Grifols Promonitor®
  • Om os
  • Nyheder
  • Kontakt os
  • Bæredygtighed
  • Aidian Academy
  • Antimicrobial resistance

Populære produkter

STANDARD™ M10 SARS-CoV-2 Test

STANDARD™ M10 SARS-CoV-2 Test

STANDARD™ M10

STANDARD™ M10

Meridian Curian® Campy

Meridian Curian® Campy

Seneste nyt

Se alt

Vitamin K can change the balance of warfarin treatment – Now is the season to monitor INR levels very carefully

25. maj 2023 | Nyheder, Produktnyheder

QuikRead go is an accurate and connectable point of care system

23. maj 2023 | Nyheder, Produktnyheder

Vi holder ferielukket: 2. pinsedag - Mandag d. 29. maj. Vi er tilbage på kontoret tirsdag d. 30. maj.

22. maj 2023 | Nyheder

  • Se alt
  • Ingen resultater fundet
  • Loading...

Nyheder

Vitamin K can change the balance of warfarin treatment – Now is the season to monitor INR levels very carefully

25. maj 2023 | Nyheder, Produktnyheder

QuikRead go is an accurate and connectable point of care system

23. maj 2023 | Nyheder, Produktnyheder

Tilbage til alle nyheder
8. september 2021
Nyheder,
AMR,
COVID-19

Antimicrobial resistance has accelerated during COVID-19

In the past decade, antimicrobial resistance (AMR) has been pointed out as an emerging global health threat. Now there are concerns that COVID-19 may have accelerated AMR due to increased use of antibiotics, although there is no scientific evidence that antibiotics would benefit in the treatment of COVID-19. Also, the increased number of hospital stays and invasive procedures in intensive care units (ICU) increased the risk for secondary bacterial infections that may require antibiotic therapy1. In ICU, ventilator associated pneumonia is a relatively common secondary infection, but patients also have urinary tract and bloodstream infections.

Antibiotics are commonly used in COVID-19 without confirmed secondary bacterial infection

At the beginning of the pandemic, antibiotics were widely used and prescribed especially for hospitalized COVID-19 patients often without an appropriate diagnosis of bacterial co-infection. As an example, in a multi-hospital cohort study in the USA, 57% of the 1705 patients received early empiric antibiotic treatment, of which only 3.5% had bacterial infection2. Another example from the USA is a study with almost 5000 participants demonstrating that during the first six months of the pandemic, 52% of the hospitalized COVID-19 patients had at least one antibiotic prescription and 36% multiple antibiotics. Up to 96% of these prescriptions were given empirically, without confirmation about the bacterial infection3. A review study evaluating the number of secondary infections in COVID-19 reported that secondary bacterial or fungal infections were in approximately 8% of the patients, but the antibiotics were prescribed for 72% of the patients4. In China, even up to 99% of the patients have received antibiotics without a diagnosed bacterial co-infection5.

CRP could aid in decreasing unnecessary antibiotic prescribing in COVID-19

Antimicrobial stewardship activities have slowly integrated into clinical guidelines that have started to recommend avoidance of antibiotics for mild and moderate COVID-19 unless there is clinical suspicion of secondary bacterial infection6,7. C-reactive protein (CRP) has been reported as a potential tool to guide antibiotic prescribing in secondary bacterial infections11. In COVID-19 patients, C-reactive protein levels are commonly slightly elevated between 20-50 mg/l8-10, whereas in hospitalized patients with secondary bacterial infection, CRP is significantly higher. A German study with 99 participants reported that patients admitted to the hospital, who develop a bacterial infection, had significantly higher CRP mean on admission (130 mg/l) and during hospital stay (mean highest CRP value 293 mg/l) compared to patients who did not have secondary infection 73 and 94 mg/l, respectively11. CRP had a sensitivity of 81% and a specificity of 76% for the detection of secondary bacterial infection, and the negative predictive value was 90% in patients with CRP < 172 mg/l. Therefore, CRP could be useful especially in ruling out bacterial coinfection and in decreasing unnecessary antibiotic prescribing.

References

  1. Cong W, Poudel AN, Alhusein N et al. Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review. Antibiotics 2021; 10(6): 745.
  2. Vaughn VM, Gandhi TN, Petty LA et al. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; 72(10): e533-e541.
  3. The PEW Charitable Trust. Could Efforts to Fight the Coronavirus Lead to Overuse of Antibiotics?, 2021.
  4. Rawson TM, Moore LSP, Zhu N et al. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; 71(9): 2459-2468.
  5. Cao J, Tu W-J, Cheng W et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; 71(15): 748-755.
  6. National Institute for Health and Care Excellence (NICE). COVID-19 Rapid Guideline: Managing COVID-19: March 2021.
  7. World Health Organization. COVID-19 Clinical management - Living guidance, 2021.
  8. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020; 395(10223): 507-513.
  9. Gao Y, Li T, Han M et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 2020; 92(7): 791-796.
  10. Mo P, Xing Y, Xiao Y et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020.
  11. Pink I, Raupach D, Fuge J et al. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19. Infection 2021.
Share
Facebook
Twitter
E-mail

Aidian Denmark ApS

Ørestads Boulevard 73,
2300 København S

Forespørgsler
info@aidian.dk

Salg
order@aidian.dk

+45 8610 3020

Fakturering adresser

Faktureringsadresse
(kun pdf-format) DK40227288@xbs-salo.com

Moms-ID 40227288

  • Kontakt os
  • Data beskyttelse
    • Persondatapolitik
    • Erklæring om beskyttelse af persondata
    • Cookie-politik
    • Social Media Policy (in English)
    • Tilbagekalde markedsføringstilladelsen
  • Aidian Academy
  • Karriere
  • Bæredygtighed
  • Produkter
    • QuikRead go
    • QuikRead 101
    • Aidian LF
    • Easicult
    • Hygicult
    • Clean Card PRO
    • Uricult
    • Cultura M
    • UniQ
    • microINR
    • Certest
    • ACRO™ Biotech
    • FACIT
    • SD BIOSENSOR STANDARD™ M10
    • SD BIOSENSOR STANDARD™ F
    • bioLytical Laboratories INSTI®
    • Nova Biomedical
    • Pulsar
    • GenSure
    • MIKROGEN serologi
    • Meridian Immunoassays
    • Meridian Curian®
    • Reagena
    • Norma Icon
    • Pixcell Medical
    • ELITech Molecular Diagnostics
    • Meridian Revogene®
    • Meridian Alethia®
    • MIKROGEN molecular diagnostics
    • Nucleix
    • Grifols Promonitor®
    • COVID-19-tests
Copyright © 2023 Aidian

Dette website bruger cookies

Vi bruger cookies til at tilpasse indhold og annoncer, til at analysere vores trafik og til at forbedre vores tjenester.

Administrer præferencer

Nødvendige (Nødvendig)

Cookies, som er nødvendige, for at websitet kan fungere korrekt. Disse omfatter cookies for adgang til sikre områder og CSRF-sikkerhed. Bemærk! Crafts standardcookies indsamler ikke personfølsomme eller andre følsomme oplysninger. Crafts standardcookies indsamler ikke IP-adresser. De oplysninger, de gemmer, sendes ikke til Pixel & Tonic eller nogen tredjeparter.
— CraftSessionId
Provider: this site
Expiration: Session
Description: Craft bruger PHP-sessioner til at vedligeholde sessioner på tværs af webanmodninger. Dette gøres via PHP-sessionscookien. Craft giver som standard denne cookie navnet “CraftSessionId”, men den kan omdøbes via phpSessionId-konfigurationsindstillingen. Denne cookie udløber, så snart sessionen lukkes.
— *_identity
Provider: this site
Expiration: Persistent
Description: Når du logger ind på kontrolpanelet, får du en godkendelsescookie, der bruges til at opretholde din godkendelsesstatus. Cookienavnet har en lang, vilkårligt genereret streng som præfiks efterfulgt af _identity. Denne cookie gemmer kun oplysninger, der er nødvendige for at opretholde en sikker, godkendt session, og den udløber, når brugeren ikke længere er godkendt i Craft.
— *_username
Provider: this site
Expiration: Persistent
Description: Beskrivelse: Hvis du markerer afkrydsningsfeltet "Keep me logged in" (Forbliv logget ind), når du logger ind, bruges denne cookie til at huske dit brugernavn ved næste godkendelse.
— CRAFT_CSRF_TOKEN
Provider: this site
Expiration: Session
Description: Beskytter både dig som bruger og os mod såkaldte Cross-Site Request Forgery (CSRF)-angreb.

Statistik

Statistikcookies hjælper os med at få indblik i, hvordan de besøgende interagerer med websites, ved at indsamle og rapportere anonyme oplysninger.

Marketing

Marketingcookies bruges til at spore besøgende på tværs af websites. De har til formål at hjælpe med at vise brugerne relevante og engagerende annoncer og er dermed mere værdifulde for både udgivere og tredjepartsannoncører.
Skjul detaljer